Tuberculosis Diagnostics Global Market Report 2026

Description

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

Tariffs are impacting the tuberculosis diagnostics market by increasing costs of imported reagents, diagnostic kits, molecular testing instruments, imaging components, and laboratory consumables. Public health systems and diagnostic laboratories in low- and middle-income regions are most affected due to dependence on imported testing supplies, while developed markets face higher equipment costs. These tariffs are raising testing expenses and affecting screening coverage. However, they are also encouraging local manufacturing of diagnostic kits, regional reagent production, and technology transfer initiatives supporting long-term diagnostic capacity building.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.34 billion in 2025 to $2.52 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to global tuberculosis disease burden, expansion of public health screening programs, availability of smear microscopy infrastructure, international funding for tb control, adoption of culture-based diagnostics.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for rapid and accurate tb diagnosis, rising focus on drug-resistant tb detection, expansion of decentralized diagnostic testing, increasing investments in molecular diagnostics, integration of ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of molecular tb testing methods, rising use of rapid diagnostic platforms, growing integration of drug resistance detection, expansion of point-of-care tb testing, enhanced focus on high-sensitivity diagnostics.

The increasing incidence of tuberculosis is expected to drive demand for tuberculosis diagnostics going forward. Tuberculosis (TB) is a highly contagious bacterial infection that primarily affects the lungs and requires prompt identification to prevent serious health complications and further transmission. The growing burden of tuberculosis is largely attributed to the rising prevalence of HIV/AIDS, which weakens the immune system and significantly increases susceptibility to developing active TB disease. This rising incidence is supporting the adoption of tuberculosis diagnostic solutions by increasing the need for rapid, accurate, and point-of-care testing that enables early initiation of treatment and improved disease management. For instance, in October 2025, according to the UK Health Security Agency, a government body responsible for health security in England, tuberculosis cases in England rose by 13.6 percent in 2024 compared to 2023, with 5,490 reported cases in 2024 versus 4,831 cases in the previous year. Therefore, the growing incidence of tuberculosis is contributing to the expansion of the tuberculosis diagnostics market.

Leading companies operating in the tuberculosis diagnostics space are prioritizing product innovation and the development of advanced diagnostic solutions to strengthen their market presence. Tuberculosis diagnostic tests include a range of medical assessments and laboratory methods used to determine whether an individual is infected with Mycobacterium tuberculosis, the bacterium responsible for TB. These tests are critical for identifying active tuberculosis, latent infections, and drug-resistant strains, allowing timely and appropriate treatment interventions. For example, in February 2023, Redcliffe Labs, an India-based technology-enabled diagnostics service provider, launched the BD MAX MDR TB test, a diagnostic solution designed to help clinicians rapidly detect tuberculosis and multidrug resistance as a first-line test. Conducted on the BD MAX molecular diagnostic system, the test enables simultaneous detection of TB-causing bacteria and identification of genetic mutations associated with resistance to two key first-line drugs, isoniazid (INH) and rifampicin (RIF).

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.00 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.

Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
Subsegments:
1) By Radiographic Tests: Chest X-rays; CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
Companies Mentioned: Beckton Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation; PerkinElmer; Thermo Fisher Scientific Inc.; Creative Diagnostics; Lionex GmbH; Biocartis; Bio-Rad Laboratories India Pvt.Ltd; Zhejiang Di'an Diagnostics Technology Co. Ltd; Kindstar Global; Siemens AG; LumiraDx Limited; TestLine Clinical Diagnostics s.r.o.; Hologic; Meridian Bioscience; Abbott Laboratories Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; Akonni Biosystems Inc; Epistem Limited; Gen-Probe; Bio Certica; BixBio
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: ME5MTDIA02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Tuberculosis Diagnostics Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Tuberculosis Diagnostics Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Tuberculosis Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Tuberculosis Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Molecular Tb Testing Methods
- 4.2.2 Rising Use Of Rapid Diagnostic Platforms
- 4.2.3 Growing Integration Of Drug Resistance Detection
- 4.2.4 Expansion Of Point-Of-Care Tb Testing
- 4.2.5 Enhanced Focus On High-Sensitivity Diagnostics

5. Tuberculosis Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Diagnostic Laboratories
5.2 Reference Laboratories
5.3 Public Health Institutions
5.4 Physician'S Office Laboratories
5.5 Research Institutes

6. Tuberculosis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tuberculosis Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Tuberculosis Diagnostics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tuberculosis Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tuberculosis Diagnostics Market Segmentation

9.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
9.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Latent Tuberculosis, Active Tuberculosis
9.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities
9.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Chest X-rays, CT Scans
9.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
9.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Interferon Gamma Release Assays (IGRAs)
9.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
GeneXpert MTB/RIF, Line Probe Assays
9.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tuberculin Skin Test (TST)
9.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Serological Tests for Antibodies
9.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Acid-Fast Bacilli (AFB) Smear Test
9.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Solid Media Cultures, Liquid Media Cultures
9.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Molecular Tests, Advanced Imaging Techniques

10. Tuberculosis Diagnostics Market Regional And Country Analysis

10.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tuberculosis Diagnostics Market

11.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tuberculosis Diagnostics Market

12.1. China Tuberculosis Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tuberculosis Diagnostics Market

13.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tuberculosis Diagnostics Market

14.1. Japan Tuberculosis Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tuberculosis Diagnostics Market

15.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tuberculosis Diagnostics Market

16.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tuberculosis Diagnostics Market

17.1. South Korea Tuberculosis Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tuberculosis Diagnostics Market

18.1. Taiwan Tuberculosis Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tuberculosis Diagnostics Market

19.1. South East Asia Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tuberculosis Diagnostics Market

20.1. Western Europe Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tuberculosis Diagnostics Market

21.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tuberculosis Diagnostics Market

22.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tuberculosis Diagnostics Market

23.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tuberculosis Diagnostics Market

24.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tuberculosis Diagnostics Market

25.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tuberculosis Diagnostics Market

26.1. Eastern Europe Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tuberculosis Diagnostics Market

27.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tuberculosis Diagnostics Market

28.1. North America Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tuberculosis Diagnostics Market

29.1. USA Tuberculosis Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tuberculosis Diagnostics Market

30.1. Canada Tuberculosis Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tuberculosis Diagnostics Market

31.1. South America Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tuberculosis Diagnostics Market

32.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tuberculosis Diagnostics Market

33.1. Middle East Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tuberculosis Diagnostics Market

34.1. Africa Tuberculosis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tuberculosis Diagnostics Market Regulatory and Investment Landscape

36. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

36.1. Tuberculosis Diagnostics Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Tuberculosis Diagnostics Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Tuberculosis Diagnostics Market Company Profiles
- 36.3.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tuberculosis Diagnostics Market Other Major And Innovative Companies

PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt. Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc

38. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

40. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Tuberculosis Diagnostics Market In 2030 - Countries Offering Most New Opportunities
40.2 Tuberculosis Diagnostics Market In 2030 - Segments Offering Most New Opportunities
40.3 Tuberculosis Diagnostics Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer